findmyKOL

Michael Ward, MD

Enriched profile

Founder/President, Verier Outcomes Research LLC (previously Chief, Clinical Trials and Outcomes Branch, NIAMS Intramural Research Program, NIH) · Verier Outcomes Research LLC

ORCIDNPI
Region🇺🇸 Bethesda, MD · Northeast · United StatesSpecialtyRheumatologyFocusRheumatoid Arthritis
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2021NIH fundingNone on fileWhy? →

Michael Ward is Founder/President, Verier Outcomes Research LLC (previously Chief, Clinical Trials and Outcomes Branch, NIAMS Intramural Research Program, NIH) at Verier Outcomes Research LLC. OpenAlex indexes 410 publications with 27,252 citations (h-index 81); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Michael M. Ward, MD, is Founder/President, Verier Outcomes Research LLC (previously Chief, Clinical Trials and Outcomes Branch, NIAMS Intramural Research Program, NIH). The public record shows 410 publications with 27,252 citations (h-index 81), centered on Rheumatoid Arthritis. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 1 companies.

  • Most recent indexed publication: 2026 · Journal of racial and ethnic health disparities
  • Top research focus: Rheumatoid Arthritis
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Rheumatoid Arthritis2 trialsAnkylosing Spondylitis / SpA1 trialSpondylitis, Ankylosing1 trialPain1 trialChronic Pain1 trialOsteoporosis1 trialHip Fractures1 trialBone Diseases, Metabolic1 trialBone Diseases1 trial

Research focus

OpenAlex concept fingerprint
Rheumatoid Arthritis

Drugs & molecules

across trials, industry payments and publications
Rybelsusgeneric · SemaglutideClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Clinical trials3Industry paymentsCodman & ShurtleffClinical trials1Industry paymentsGeorgetown UniversityClinical trials1Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
410publications

Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.

27,252citations

Total citations across indexed works.

81h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
1companies · 2021–2021

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Other

    verieroutcomes.com/about

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →verieroutcomes.com
  • ResearchGate

    researchgate.net/scientific-contributions/Michael-M-Ward-39184767

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/michael-ward-md-787046198

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • LinkedIn

    LinkedIn profile "Michael Ward MD - Verier Outcomes Research LLC" (auth-walled; corroborated via SERP snippet showing name + Verier Outcomes Research LLC employer match)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of Illinois College of Medicine at Chicago

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctor.webmd.com
  • M.P.H.

    University of Michigan

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →verieroutcomes.com
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →verieroutcomes.com
  • Residency

    University of Michigan

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →verieroutcomes.com
  • Fellowship

    Duke University

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →verieroutcomes.com
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →verieroutcomes.com

Editorial & leadership roles

journal and society appointments
  • Methodologist

    European Alliance of Associations for Rheumatology (EULAR)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →verieroutcomes.com
  • Former Associate Editor

    Arthritis & Rheumatology and Arthritis Care & Research (16 years combined)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →verieroutcomes.com
  • Editorial board member

    Annals of the Rheumatic Diseases

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →verieroutcomes.com

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Q&A interview

    "Michael Ward, MD, PhD, on RAPID3 for Rheumatoid Arthritis" -- discussed his research on Minimal Clinically Important Improvement of RAPID3 in RA (published while at NIAMS/NIH)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.